Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | STSA | AMGN | VRTX | BMY | GILD |
| Company | Satsuma Pharmaceuticals Inc | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 1.1100 | 319.59 | 503.00 | 59.82 | 96.35 |
| High | 1.1400 | 321.22 | 508.04 | 60.62 | 96.84 |
| Low | 1.0100 | 293.80 | 489.02 | 58.81 | 94.22 |
| Last | 1.1000 | 298.84 | 490.00 | 59.02 | 94.35 |
| Change | -0.0100 | -22.97 | -11.72 | -0.80 | -2.68 |
| % Change | -0.90% | -7.14% | -2.34% | -1.34% | -2.76% |
| Volume | 1,829,700 | 6,673,500 | 1,364,300 | 15,140,815 | 9,322,100 |
| 20-Day Average Volume | 576,695 | 2,132,140 | 1,151,700 | 10,482,550 | 6,381,660 |
| Previous Close | 1.1100 | 321.81 | 501.72 | 59.82 | 97.03 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.0658 | 318.13 | 484.39 | 54.24 | 90.07 |
| 20-Day Raw Stochastic | 69.23% | 14.63% | 47.33% | 77.78% | 65.79% |
| 20-Day Relative Strength | 58.87% | 34.02% | 53.21% | 66.38% | 66.87% |
| Weighted Alpha | -14.90 | +6.61 | +34.01 | +26.62 | +35.61 |
| Today's Opinion | 8% Buy | 40% Sell | 88% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 8% Buy | 8% Buy | 88% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 8% Sell | 56% Buy | 48% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.76% since 05/31/23 | -6.40% since 11/05/24 | -1.98% since 11/05/24 | +5.49% since 11/05/24 | +4.58% since 11/05/24 |
| Low | 1.0100 on 06/07/23 | 293.80 on 11/12/24 | 485.29 on 11/06/24 | 53.97 on 11/08/24 | 90.50 on 11/06/24 |
| High | 1.1400 on 06/07/23 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 1-Month | |||||
| %Chg | +2.80% since 05/05/23 | -8.99% since 10/11/24 | +1.72% since 10/11/24 | +13.07% since 10/11/24 | +11.07% since 10/11/24 |
| Low | 1.0100 on 06/07/23 | 293.80 on 11/12/24 | 463.14 on 11/01/24 | 51.31 on 10/15/24 | 84.34 on 10/14/24 |
| High | 1.1400 on 06/07/23 | 328.25 on 11/08/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +16.17% since 03/07/23 | -6.61% since 08/12/24 | +5.49% since 08/12/24 | +25.41% since 08/12/24 | +29.26% since 08/12/24 |
| Low | 0.6550 on 04/14/23 | 293.80 on 11/12/24 | 447.70 on 10/07/24 | 46.88 on 08/22/24 | 72.67 on 08/13/24 |
| High | 1.4700 on 04/17/23 | 339.17 on 09/23/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +31.28% since 12/07/22 | -3.65% since 05/10/24 | +15.90% since 05/10/24 | +31.33% since 05/10/24 | +43.04% since 05/10/24 |
| Low | 0.6550 on 04/14/23 | 293.80 on 11/12/24 | 422.44 on 05/14/24 | 39.35 on 07/05/24 | 62.07 on 05/31/24 |
| High | 1.4700 on 04/17/23 | 346.85 on 07/25/24 | 519.88 on 11/08/24 | 61.08 on 11/11/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 36,467 | 172,983,504 | 129,207,448 | 121,325,552 | 120,801,568 |
| Shares Outstanding, K | 33,152 | 537,533 | 257,529 | 2,028,177 | 1,244,992 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 27,116,000,000 |
| Annual Net Income | -70,060,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,503,000,000 | 2,771,900,000 | 11,892,000,000 | 7,545,000,000 |
| Last Quarter Net Income | -10,290,000 | 2,830,000,000 | 1,045,400,000 | 1,211,000,000 | 1,253,000,000 |
| 60-Month Beta | 0.10 | 0.60 | 0.39 | 0.44 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.31 on 05/11/23 | 5.58 on 10/30/24 | 4.38 on 11/04/24 | 1.80 on 10/31/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 05/16/23 | 10/30/24 | 11/04/24 | 10/31/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | 0.600 on 10/04/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | 03/28/14 | 11/18/24 | N/A | 10/04/24 | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.92 | 0.00 | 46.27 | 21.80 |